• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    MPO's 2023 Medical Device Industry Year in Review

    The Beat Goes On in the Cardiovascular Device Market

    Medical Manufacturers Gain Support from 3D Printing

    The Intelligent Tools Medical Device Manufacturers Already Own

    MPO's 2023 Medtech Supply Chain Survey
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    MPO's Most-Read Stories This Week—Dec. 9

    Babson Diagnostics’ BetterWay Achieves Regulatory Milestone

    WhiteSwell Successfully Treats Acute Decompensated Heart Failure in Study

    Everly Health Releases At-Home Collection Kidney Health Test

    Kenco Adds Two to its Life Sciences Division Team
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    MPO's 2023 Medical Device Industry Year in Review

    The Beat Goes On in the Cardiovascular Device Market

    Medical Manufacturers Gain Support from 3D Printing

    The Intelligent Tools Medical Device Manufacturers Already Own

    MPO's 2023 Medtech Supply Chain Survey
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    A Peek Into the 2028 MPO Summit

    Retail Healthcare Disruptors and Medical Devices

    Six Developments Your Talent Strategy Should Prepare for in 2024

    The Power and Paradox of Never

    Navigating the Q-Sub Program: How Experienced Lab Partners Can Help Streamline Regulatory Submission
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Arthur G Russell Company, The

    Qosina Corp.

    Cirtec Medical

    Providence Enterprise USA Inc.

    Medbio LLC
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Telemedicine for Neurology: 5 Benefits of Remote Management

    Machining 101: A Review of Machining Components with a Five-Axis System

    MedTech 2024: Top 5 Trends Shaping a Dynamic Industry

    Early Warning: A Q&A with Abbott's CMO of Heart Failure

    2023 in Review: Medtech's Mega-M&A Is MIA
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Arthur G Russell Company, The

    Qosina Corp.

    Cirtec Medical

    Providence Enterprise USA Inc.

    Medbio LLC
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    U.S. May Offer a Safe Harbor from the Impending MDR Storm

    U.S. may represent the preferred route to market with regulatory changes elsewhere in the world, like the EU's MDR.

    U.S. May Offer a Safe Harbor from the Impending MDR Storm
    Dawn A. Lissy, President & Founder, Empirical09.06.19
    My last column was a bit of a downer. I wrote about all the concerns I have with the changes coming from the European Medical Device Regulation (MDR) set to take effect in May 2020. (Spoiler alert—there were many.) While I still hold the opinion that the effects of MDR will leave our industry FUBAR across the pond, I’m now focusing on the bright side here in the United States, where the forecast for medical device developers is considerably brighter.

    Political winds have shifted. In 2013, the medical device tax sent some major players running to Europe to avoid the 2.3 percent up-front revenue tax. That tax has been repeatedly suspended by U.S. Congress, and the current bill to repeal it has rare bipartisan support.

    There are other factors that make for a more inviting environment for the medical device industry in the United States. The U.S. Food and Drug Administration (FDA) seems to recognize America is in line to receive the overflow from companies that won’t receive CE marks under MDR.

    My colleague Meredith May, vice president of Empirical Consulting, is my go-to source on all things regulatory. Based on what we’re seeing in the industry, we predict a significant shift in how devices are developing on the global stage. Clients that would typically work to obtain a CE mark before a 510(k) are now taking the opposite approach.

    “MDR is disrupting the EU market and much of the world,” she said. “Pre-MDR, it was faster to get a device into the EU market because the review process was controlled by [the developer]. All you had to prove was safety. In the U.S., we have to prove safety, efficacy, and substantial equivalent.”

    “It used to be really easy—you might have to have clinical trials in the U.S., but it was almost guaranteed you didn’t need it in the EU. Now it’s more likely you’ll need clinical investigation in Europe than in the U.S.”

    That means higher costs and more time, perhaps two to three times longer, to meet MDR requirements than a 510(k).

    “Your Class II device likely will not require clinical trials and investigation, which can cost anywhere from about $300,000 to about $2 million and take an extra nine months to five years depending on your end points,” May said. “No startups that I know of could manage that. That’s a huge financial and resource burden for startups.”

    That’s assuming you can find a notified body certified under MDR. Currently, only three of 58 European notified bodies are certified, and they’ve stopped taking new applications for CE marks due to the backlog of companies trying to renew their CE marks before May 2020. But FDA is up to date and moving forward with new 510(k)s. They’re also consistently releasing guidance documents, something MDR has yet to begin.

    “Even if you are trying to stick it out in Europe, you won’t know how to do that,” May said.

    Another FDA effort to speed the path to market: the Payor Communication Task Force. The program to facilitate early conversations with insurance companies and others is not a new resource—it launched in 2014. But it’s now generating more momentum and buy-in from developers wanting to be better positioned for having a device not just cleared for use in the patient, but also blessed for coverage by insurance companies.

    It seems like a no-brainer: If the FDA says a device is safe, it should be a viable treatment option. But the bar is different. FDA wants proof that a device is safe and effective. Payors want to know a device improves health outcomes and is reasonable and necessary for their beneficiaries. These different payor standards may require different data from what the FDA reviewed, which can result in limited or no coverage after a company or innovator has spent substantial time and money to earn FDA approval or clearance.

    To further complicate the issue, a device may earn national and/or local coverage, meaning your hometown hospital may not cover the same devices as the Mayo Clinic. Again, this comes back to different data sets and expectations that can add time and cost to the development timeline if they’re not addressed early on.

    The Payor Communication Task Force facilitates conversations about data development, and the innovator may choose to incorporate payor suggestions into a device’s development plan. Rather than adding time and cost after marketing approval is obtained from FDA, device developers who work with the task force get suggested parameters and recommendations from payors to better position their device for reimbursement once it’s cleared or approved by FDA.

    It’s yet another example of how FDA is working to support patient access to innovative medical devices and for device developers, which we’re just not seeing in Europe right now.

    “If you take all of those things and look at them, the FDA is trying to have a more transparent and consistent process, whereas the MDR is creating a more muddled and confusing process in addition to adding time and cost,” May said. “In a sense, the FDA is trying to make it easier, not harder. The EU is trying to make it harder, not easier.”

    I remain hopeful the EU will come up with solutions for the current backlog and better processes for the future. Until then, we’re working to keep up with the market shift and do our part to support our industry. I trust that bright minds and commitment to best patient outcomes will eventually prevail, but hope that happens before May 2020. 


    Dawn Lissy is a biomedical engineer, entrepreneur, and innovator. Since 1998, the Empirical family of companies (Empirical Testing Corp., Empirical Consulting LLC, and Empirical Machine, LLC) has operated under Lissy’s direction. Empirical offers the full range of regulatory and quality systems consulting, testing, small batch and prototype manufacturing, and validations services to bring a medical device to market. Empirical is very active within standards development organization ASTM International and has one of the widest scopes of test methods of any accredited independent lab in the United States. Because Lissy was a member of the U.S. Food and Drug Administration’s Entrepreneur-in-Residence program, she has first-hand, in-depth knowledge of the regulatory landscape. Lissy holds an inventor patent for the Stackable Cage System for corpectomy and vertebrectomy. Her M.S. in biomedical engineering is from The University of Akron, Ohio. 
    Related Searches
    • test
    • device tax
    • biomedical
    • patent
      Loading, Please Wait..

      Breaking News
      • MPO's Most-Read Stories This Week—Dec. 9
      • Babson Diagnostics’ BetterWay Achieves Regulatory Milestone
      • WhiteSwell Successfully Treats Acute Decompensated Heart Failure in Study
      • Everly Health Releases At-Home Collection Kidney Health Test
      • Kenco Adds Two to its Life Sciences Division Team
      View Breaking News >
      CURRENT ISSUE

      November 2023

      • MPO's 2023 Medical Device Industry Year in Review
      • The Beat Goes On in the Cardiovascular Device Market
      • Medical Manufacturers Gain Support from 3D Printing
      • The Intelligent Tools Medical Device Manufacturers Already Own
      • View More >

      Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
      You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

      • About Us
      • Privacy Policy
      • Terms And Conditions
      • Contact Us

      follow us

      Subscribe
      Nutraceuticals World

      Latest Breaking News From Nutraceuticals World

      Women in Nutraceuticals Hires Executive Director Rebecca Takemoto
      FDA Issues Interim Response to Nammex’s Mushroom Labeling Petition
      MSM Linked to Improvements in Knee Pain
      Coatings World

      Latest Breaking News From Coatings World

      Weekly Recap: PPG, PPG Asian Paints, AkzoNobel Top This Week’s Stories
      Orion S.A. Has Four Carbon Black Plants Awarded ISCC PLUS
      Peninsula Polymers Acquires New Distribution Center in Indiana
      Medical Product Outsourcing

      Latest Breaking News From Medical Product Outsourcing

      MPO's Most-Read Stories This Week—Dec. 9
      Babson Diagnostics’ BetterWay Achieves Regulatory Milestone
      WhiteSwell Successfully Treats Acute Decompensated Heart Failure in Study
      Contract Pharma

      Latest Breaking News From Contract Pharma

      FDA Approves Bio-Thera's Biosimilar Referencing Roche’s Avastin
      Full-Life Technologies to Build GMP Radiopharmaceuticals Mfg. Facility
      Innovent Biologics, Synaffix Expand ADC Licensing Deal
      Beauty Packaging

      Latest Breaking News From Beauty Packaging

      COSRX’s Latest TikTok Campaign Accumulates 3.2B Views on TikTok
      Christian Louboutin Taps Morgane Martini as Global Makeup Artist
      Shiseido Forms New Venture Fund
      Happi

      Latest Breaking News From Happi

      Christian Louboutin Names Morgane Martini Global Makeup Artist
      Estée Lauder Lead Scientist Dr. Nadine Pernodet To Lecture At SCC Science Meeting
      Topical Testosterone Formulation for Chest Hair Growth
      Ink World

      Latest Breaking News From Ink World

      Weekly Recap: Siegwerk, DIC, and Müller Martini Top This Week’s Stories
      Orion S.A. Now Has Four Carbon Black Plants Awarded ISCC PLUS
      BASF Commits to Scope 3.1 Emissions Targets
      Label & Narrow Web

      Latest Breaking News From Label & Narrow Web

      Analyzing the Russian label market, Carter boosts brands and more
      FLAG’s December Lunch & Learn to feature Omet
      UPM Raflatac releases neuromarketing study findings
      Nonwovens Industry

      Latest Breaking News From Nonwovens Industry

      Ginni Strikes Deal to Sell Spinning, Knitting Operations
      Campen Machinery Announces Patent Pending Status for Airlaid Trays
      Veocel Partners with Beauty and Feminine Care Brands in Asia Pacific
      Orthopedic Design & Technology

      Latest Breaking News From Orthopedic Design & Technology

      ODT's Most-Read Stories This Week—Dec. 9
      Fujitsu, iSurgery Launch Bone Health Promotion Project in Japan
      Wenzel Spine Hires Dr. Robert Gordon as Executive Chairman
      Printed Electronics Now

      Latest Breaking News From Printed Electronics Now

      Weekly Recap: Schreiner MediPharm, GIANCE and PragmatIC Top This Week’s Stories
      Intel CEO Pat Gelsinger to Cover AI During CES 2024 Keynote
      Ciena Invests in US Manufacturing with Flex

      Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

      AD BLOCKER DETECTED

      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker.


      FREE SUBSCRIPTION Already a subscriber? Login